億嘉和(603666.SH):控股股東、實際控制人《一致行動人協議》到期終止
格隆匯6月12日丨億嘉和(603666.SH)公佈,近日,公司收到控股股東、實際控制人朱付雲女士與股東張靜女士《關於<一致行動人協議>到期不續簽暨權益變動的吿知函》,雙方決定前期簽署的《一致行動人協議》於2024年6月11日到期後不再續簽;同日,公司收到朱付雲女士、南京瑞蓓、張靜女士和程敏先生出具的《簡式權益變動報吿書》,因朱付雲女士與張靜女士一致行動關係終止,導致朱付雲女士擁有權益的股份自公司2021年非公開發行股票至今累計變動超過5%。本次權益變動未導致公司控股股東及實際控制人發生變化,公司控股股東、實際控制人仍為朱付雲女士。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.